(Press-News.org) Although people generally talk about "cancer", it is clear that the disease occurs in a bewildering variety of forms. Even single groups of cancers, such as those of the white blood cells, may show widely differing properties. How do the various cancers arise and what factors determine their progression? Clues to these two issues, at least for leukaemias, have now been provided by Boris Kovacic and colleagues at the University of Veterinary Medicine, Vienna (Vetmeduni Vienna). The results are published in the current issue of the journal EMBO Molecular Medicine and have extremely important consequences for the treatment of a particularly aggressive type of leukaemia.
It is well known that many types of cancer arise as a result of a mutation within a cell and prevailing wisdom has held that the stage of differentiation of this cell determines exactly what form of cancer develops. For example, it was believed that so-called chronic myeloid leukaemia or CML arises from bone marrow stem cells, while a different type of leukaemia, known as B-cell acute lymphoid leukaemia or B-ALL, results from B-cell precursors. This belief has been spectacularly refuted by the latest results from Boris Kovacic and colleagues in the Vetmeduni Vienna's institutes of Animal Breeding and Genetics and of Pharmacology and Toxicology.
The researchers have now shown that both CML and B-ALL arise from the most primordial kind of blood cell (long-term haematopoietic stem cells), although the pathways by which the diseases progress are different. The usual causes of CML and B-ALL are two highly related versions of the same oncogene, BCR/ABL. If the primordial blood cells are transformed – or made potentially cancerous – by a particular version of BCR/ABL, for technical reasons termed BCR/ABLp210, the result is chronic myeloid leukaemia or CML. The long-term haematopoietic stem cells remain and act as the dreaded cancer stem cells, or CSCs, which ensure that the disease persists. Curing chronic myeloid leukaemia requires the complete elimination of the CSCs. However, if the long-term haematopoietic stem cells are transformed by a related version of BCR/ABL, BCR/ABLp185, the result is a highly aggressive form of leukaemia, B-ALL. The finding that B-ALL actually originates from the same stem cells as CML was both unexpected and highly provocative.
Kovacic and colleagues have shown further that B-ALL only develops if the transformed stem cell is exposed to a particular growth factor, interleukin-7. If interleukin-7 is present (it usually is), the transformed long-term haematopoietic stem cells undergo a differentiation step to CSCs, which in this case correspond to pro-B cells. If interleukin-7 is absent during the initial phase of transformation, B-ALL cannot develop.
In other words, two distinct types of cell are involved in leukaemia development, the primordial cells (also termed the cells of origin of cancer) and the cancer stem cells that cause the disease to progress. Unless the CSCs are eliminated, fresh cancer cells can arise at any time and the leukaemia will recur. The problem is that current leukaemia therapies are not designed to target CSCs. The primordial CSCs in CML are highly quiescent and thus difficult to target. In contrast, the CSCs in B-ALL are abundant and have a high turnover rate, which makes them susceptible to treatment. Treatment of B-ALL may thus succeed in eliminating most CSCs but if even a single cell remains intact it is likely that the patient will relapse, possibly with an even more aggressive form of leukaemia. "A therapy that targets the bulk of tumour cells will not work," as Kovacic succinctly summarizes his results. "To treat B-ALL successfully it will be necessary for us to learn much more about the development of the disease. A combined therapy is required, so future work should aim at developing drugs that target the long-term haematopoietic stem cells from which B-ALL is derived."
###The paper "Diverging fates of cells of origin in acute and chronic leukemia" by Boris Kovacic, Andrea Hoelbl, Gabriele Litos, Memetcan Alacakaptan, Christian Schuster, Katrin M. Fischhuber, Marc A. Kerenyi, Gabriele Stengl, Richard Moriggl, Veronika Sexl and the late Hartmut Beug is published in the current issue of the journal "EMBO Molecular Medicine" (2012, Vol. 4 pp. 283-297).
The work was initiated at the Research Institute of Molecular Pathology (IMP) and was performed together with groups at the Medical University of Vienna and the Ludwig Boltzmann Institute for Cancer Research in Vienna.
The scientific article in full text online (Open Access):
http://onlinelibrary.wiley.com/doi/10.1002/emmm.201100208/full
About the Vienna University of Veterinary Medicine
The University of Veterinary Medicine, Vienna is the only academic and research institution in Austria that focuses on the veterinary sciences. About 1000 employees and 2300 students work on the campus in the north of Vienna, which also houses the animal hospital and various spin-off-companies.
http://www.vetmeduni.ac.at
Scientific contact:
Dr Boris Kovacic, E Boris.Kovacic@vetmeduni.ac.at, T +43 1 25077-5622
Distributed by:
Klaus Wassermann, E Klaus.Wassermann@vetmeduni.ac.at, T +43 1 25077-1153
Leukaemia cells have a remembrance of things past
2012-04-25
ELSE PRESS RELEASES FROM THIS DATE:
Family life study reveals key events that can trigger eating disorders
2012-04-25
Eating disorders can be triggered by lack of support following traumatic events such as bereavement, relationship problems, abuse and sexual assault, according to research published in the May issue of the Journal of Clinical Nursing. Even changing school or moving home can prove too much for some young people and lead to conditions such as anorexia or bulimia.
Researchers from the University of Minnesota, USA, spoke to 26 women and one man aged from 17 to 64 receiving treatment from a specialist outpatient clinic. They had suffered from eating disorders for an average ...
BGI debuts 'EasyGenomics' cloud-based bioinformatics solution for omics-related research
2012-04-25
April 24, 2012, Cambridge, Mass. and Shenzhen, China – BGI, the world's largest genomics organization, introduced today its latest-generation cloud-based Software as a Service (SaaS) solution, EasyGenomics, at the 10th Bio-IT World Conference & Expo being held April 24 to 26 in Boston, Mass. EasyGenomics allows scientists to easily access data-heavy omics-related research with rapid turnaround time, reliable results, real-time data monitoring, and a user-friendly interface. EasyGenomics integrates various popular next generation sequencing (NGS) analysis workflows including ...
RANK protein promotes the initiation, progression and metastasis of human breast cancer
2012-04-25
Researchers from the Bellvitge Biomedical Research Institute (IDIBELL) have shown that overactivation of the RANK signalling pathway promotes the initiation, progression and metastasis of tumours in human breast epithelial cells by dedifferentiation of breast cells to stem cells. The results of this study have been advanced in the electronic edition of the journal Cancer Research.
RANK signalling pathway
The study was coordinated by Eva Gonzalez-Suarez, head of the IDIBELL research group on Transformation and Metastasis. A year ago, the team published a paper which ...
Cassini sees new objects blazing trails in Saturn ring
2012-04-25
Queen Mary scientists working with images from NASA's Cassini spacecraft have discovered strange half-mile-sized objects punching through parts of Saturn's F ring, leaving glittering trails behind them.
These trails in the rings, which scientists are calling 'mini-jets', fill in a missing link in our understanding of the curious behaviour of the F ring. The results will be presented today (24 April) at the European Geosciences Union meeting in Vienna, Austria.
Scientists have known that relatively large objects like the moon Prometheus (as long as 92 miles across) ...
Prions in the brain eliminated by homing molecules
2012-04-25
Toxic prions in the brain can be detected with self-illuminating polymers. The originators, at Linköping University in Sweden, has now shown that the same molecules can also render the prions harmless, and potentially cure fatal nerve-destroying illnesses.
Linköping researchers and their colleagues at the University Hospital in Zürich tested the luminescent conjugated polymers, or LCPs, on tissue sections from the brains of mice that had been infected with prions. The results show that the number of prions, as well as their toxicity and infectibility, decreased drastically. ...
An unexpected virus reservoir
2012-04-25
Where do viruses dangerous to humans come from, and how have they evolved? Scientists working with Prof. Dr. Christian Drosten, Head of the In¬stitute for Virology at the Universitätsklinikum Bonn, have made significant progress in answering this question. "We already knew from prior studies that bats and rodents play a role as carriers of paramyxoviruses," said Prof. Drosten. The many varied members of this large virus family cause, e.g., measles, mumps, pneumonias and colds. The highly dangerous Hendra and Nipah viruses cause types of encephalitis that result in death ...
Mysterious 'monster' discovered by amateur paleontologist
2012-04-25
Around 450 million years ago, shallow seas covered the Cincinnati region and harbored one very large and now very mysterious organism. Despite its size, no one has ever found a fossil of this "monster" until its discovery by an amateur paleontologist last year.
The fossilized specimen, a roughly elliptical shape with multiple lobes, totaling almost seven feet in length, will be unveiled at the North-Central Section 46th Annual Meeting of the Geological Society of America, April 24, in Dayton, Ohio. Participating in the presentation will be amateur paleontologist Ron ...
'Inhabitants of Madrid' ate elephants’ meat and bone marrow 80,000 years ago
2012-04-25
Humans that populated the banks of the river Manzanares (Madrid, Spain) during the Middle Palaeolithic (between 127,000 and 40,000 years ago) fed themselves on pachyderm meat and bone marrow. This is what a Spanish study shows and has found percussion and cut marks on elephant remains in the site of Preresa (Madrid).
In prehistoric times, hunting animals implied a risk and required a considerable amount of energy. Therefore, when the people of the Middle Palaeolithic (between 127,000 and 40,000 years ago) had an elephant in the larder, they did not leave a scrap.
Humans ...
ORNL, Yale take steps toward fast, low-cost DNA sequencing device
2012-04-25
Researchers at Oak Ridge National Laboratory and Yale University have developed a new concept for use in a high-speed genomic sequencing device that may have the potential to substantially drive down costs.
"The low cost--if it can be achieved--would enable genomic sequencing to be used in everyday clinical practice for medical treatments and preventions," said Predrag Krstic, project director and former ORNL physicist now at the University of Tennessee-ORNL Joint Institute for Computational Sciences.
The research is part of a nearly decade-long drive by the National ...
Soy-based S-equol supplement reduces hot flash frequency, muscle & joint pain in US women
2012-04-25
Northridge, Calif. (April 24, 2012) – A dose of 10 milligrams (mg) daily of S-equol delivered via a newly developed fermented soy germ-based nutritional supplement is as effective as a standard dose of soy isoflavones at reducing hot flash frequency significantly and is even more effective for relieving muscle and joint pain, according to a peer-reviewed study in US postmenopausal women published in the June Journal of Women's Health, available now as a Fast Track article online ahead of print.
"This study provides evidence that daily doses of the supplement S-equol, ...